VIVUS 3.75/23 (Qsymia phentermine hydrochloride 3.75 mg (base) / topiramate extended-release 23 mg)
Generic Name: phentermine/topiramate
Pill with imprint VIVUS 3.75/23 is Purple, Capsule-shape and has been identified as Qsymia phentermine hydrochloride 3.75 mg (base) / topiramate extended-release 23 mg. It is supplied by Vivus, Inc..
Qsymia is used in the treatment of weight loss; obesity and belongs to the drug class anorexiants. Not for use in pregnancy. Qsymia phentermine hydrochloride 3.75 mg (base) / topiramate extended-release 23 mg is classified as a Schedule 4 controlled substance under the Controlled Substance Act (CSA).
Images for VIVUS 3.75/23
Qsymia
- Generic Name
- phentermine/topiramate
- Imprint
- VIVUS 3.75/23
- Strength
- phentermine hydrochloride 3.75 mg (base) / topiramate extended-release 23 mg
- Color
- Purple
- Size
- 12.00 mm
- Shape
- Capsule-shape
- Availability
- Prescription only
- Drug Class
- Anorexiants
- Pregnancy Category
- X - Not for use in pregnancy
- CSA Schedule
- 4 - Some potential for abuse
- Labeler / Supplier
- Vivus, Inc.
- National Drug Code (NDC)
- 62541-0201
- Inactive Ingredients
-
sucrose,
corn starch,
microcrystalline cellulose,
povidone k30,
magnesium silicate,
titanium dioxide,
FD&C Blue No. 1,
FD&C Red No. 3
Note: Inactive ingredients may vary.
Submitted by: pillstress
More about Qsymia (phentermine / topiramate)
- Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Drug Interactions
- Compare Alternatives
- Support Group
- Pricing & Coupons
- En Español
- 548 Reviews
- Drug class: anorexiants
- FDA Alerts (1)
- FDA Approval History
Consumer resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.